NEW YORK (GenomeWeb News) – Promega and One Lambda have agreed to co-market Promega’s DNA extraction systems with One Lambda’s human leukocyte antigen tests, Promega said yesterday.
Under the agreement, the companies will market the Promega Maxwell 16 DNA extraction system along with One Lambda’s LABType SSO and Micro SSP tests to customers in the HLA market.
One Lambda VP of R&D Jar-How Lee said in a statement that Promega’s system “helps ensure consistent, reliable results” for One Lambda’s assays, and it helps eliminate problems with poor sample preparation. “Suboptimal sample extraction can lead to time-consuming rework and system failure, which slow results, decrease productivity and potentially compromise overall accuracy of the tests,” Lee added.
The Maxwell 16 System extracts DNA from blood, buffy coat, or buccal swabs in about 30 minutes to 40 minutes, and it reduces labor, reagents, and assay time, Promega said.